NSNikita G. Sidorov

Nikita G. Sidorov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nikita G. Sidorov has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of a Nasal Spray Based on an Antigen Complex from Opportunistic Bacteria in Experimental Models of SARS-CoV-2 and Influenza A Infection

    by Nikita Sidorov, Alena Soldatenkova, Stanislav Kedik, Natalia Michailova, Elvira Kudryavtseva, Elena Afanasyeva, Alexey Panov, Vladimir Gureev

    Background/Objectives: Acute respiratory infections represent a global health burden due to their high incidence, morbidity and mortality. Despite advances in prevention and treatment, strategies providing broad protection against respiratory pathogens remain limited. This study evaluated the antiviral activity of nasal spray forms based on an antigen complex from opportunistic bacteria, with or without a mucoadhesive copolymer, and their influence on cellular and humoral components of the immune response. Methods: Antiviral activity was assessed in experimental models of SARS-CoV-2 infection in Syrian hamsters and influenza A pneumonia in mice under prophylactic and therapeutic–prophylactic regimens. Parameters of cellular and humoral immune response were assessed using delayed-type hypersensitivity, antibody-forming cell assays, and leukocyte phagocytic activity. Results: Both forms showed comparable influence on cellular and humoral components of the immune response. In a mouse model of lethal influenza pneumonia induced by A/California/04/2009 (H1N1)pdm09 virus, intranasal administration at 100 µg/kg increased mean survival time and survival rate, and reduced body weight loss. In SARS-CoV-2-infected hamsters, both forms reduced clinical signs, body weight loss, weight lung index, lung pathology, and decreased viral titers. The copolymer-containing form showed the most pronounced effect under the therapeutic–prophylactic regimen, with greater protection against body weight loss and stronger suppression of viral replication. Conclusions: The findings support further investigation of these nasal spray forms as candidates for prophylaxis and adjunctive therapy of respiratory infections, particularly when pathogen variability may limit the effectiveness of pathogen-directed treatments. Further mechanistic studies are needed to clarify the pathways underlying the observed antiviral effect.

  • Open Access

    Antigen complex of opportunistic bacteria: Assessment of protective properties and toxicity in mice

    by A. V. Soldatenkova, N. G. Sidorov, S. A. Lazarev, A. P. Zherebtsov, N. A. Mikhailova

    INTRODUCTION . Medicinal products based on various bacterial antigens effectively prevent diseases caused by opportunisitic bacteria. However, their large-scale use will require improved composition and production process. A promising approach is to develop an antigen complex from Klebsiella pneumoniae , Escherichia coli , Proteus vulgaris , and Staphylococcus aureus . AIM . This study aimed to examine protective properties and toxicity of antigens from K. pneumoniae , E. coli , P. vulgaris , S. aureus , and the antigen complex in experiments on mice. MATERIALS AND METHODS . Antigens of K. pneumoniae 204, E. coli F147, P. vulgaris 177, the complex of two S. aureus antigens (1986 and 1991), and the complex of the above antigens were used in the study. Toxicity was evaluated in white male and female SHK mice weighing 18–20 g. A single dose of antigens (50, 100 or 200 μg per mouse) or antigen complex (0.1, 0.2, 0.4, 0.6 mL per mouse) was injected intraperitoneally. Protective properties were studied in female SHK mice weighing 14–16 g. Animals were immunised twice and then infected with live homologous strains of K. pneumonia 204, E. coli F147, P. vulgaris 177, S. aureus 1986, and P. aeruginosa PA103 heterologous strain. For seven days, their survival was monitored; LD50 value and efficiency index was determined. RESULTS . E. coli , S. aureus and P. vulgaris antigens at all tested doses, and K. pneumoniae antigens at doses of 50 and 100 µg, did not cause toxic effects in mice. 200 µg of K. pneumoniae antigens caused weight loss and animal mortality. Injection of 0.1–0.4 mL of the antigen complex did not cause toxic effects; however, injection of 0.6 mL resulted in manifestations of toxicity. Double immunisation with 0.1 mL antigen complex protected mice against infection with homologous and heterologous strains. Efficiency index was 7.99 for K. pneumonia 204, 11.56 for E. coli F147, 25.90 for P. vulgaris 177, 7.45 for S. aureus 1986, and 4.00 for P. aeruginosa PA103 (рCONCLUSIONS . Test antigens of K. pneumoniae , E. coli , P. vulgaris , S. aureus , and the antigen complex had an acceptable toxicological profile. The antigen complex has shown significant protective properties both against homologous strains ( K. pneumoniae , E. coli , P. vulgaris , and S. aureus ) and heterologous strain of P. aeruginosa . Thus, the studied antigens and their complex can be used to develop a medicinal product preventing a wide range of opportunistic bacterial infections.

  • Study of the Effect of Palmitic Acid on the Expression of Myostatin mRNA and its Cytotoxic Properties in the Culture of Myoblast Cells and the Possibility of Exogenous Regulation

    by Vladimir G. Kukes, Vladimir A. Furalyov, Albina А. Gazdanova, Olga K. Parfenova, Dmitry V. Grishin, Nikita G. Sidorov

    Objective: To study the cytotoxic effect of palmitic acid on myoblasts in vitro and the influence of this toxicant on the expression of myostatin mRNA in myoblast culture. Methods: To research the protective action against these processes of a compound with antioxidant activity, for which 2-ethyl-6-methyl-3-hydroxypyridine malate (ethoxidol) was chosen. Results: Our studies have shown that palmitic acid has a noticeable cytostatic effect on myoblasts in vitro, significantly suppressing their proliferation: the rate of MTT recovery in myoblasts treated with palmitate was only 9.6% of that rate in control myoblasts. In experiments, it was shown that palmitic acid slightly activated the expression of myostatin mRNA. At the same time, the protective effect of 2-ethyl-6-methyl-3-hydroxypyridine malate was not so pronounced. Conclusion: The results of our research indicate that the activation of myostatin synthesis is not one of the main causes of the development of myodystrophy in obese people or people following a high-lipid diet, while the direct cytotoxic effect of palmitic acid on myoblasts is. It is obvious that the use of antioxidants such as ethoxide has a protective effect on myoblasts in the experiment and may have a certain potential in clinical practice.

  • Open Access

    Study of the Protective Properties of 2-Ethyl-6-Methyl-3-Hydroxypyridine Malate in the Model of In vitro-Induced Oxidative Stress in Myoblast Cell Culture

    by Vladimir A. Furalyov, Vladimir G. Kukes, Albina А. Gazdanova, Olga K. Parfenova, Nikita G. Sidorov, Roman V. Kurkin

    Background: A cellular model of oxidative stress induced by hydrogen peroxide in the primary culture of myoblasts was obtained by in vitro experiments, and the possibility of exogenous regulation of the cytotoxic effect using 2-ethyl-6-methyl-3-hydroxypyridine malate (ethoxidol) was studied. Moreover, the influence of oxidative stress and the effect of ethoxidol on the intracellular expression of such an important biomarker as myostatin was investigated. Methods: Hydrogen peroxide was used to induce oxidative stress. The effect of hydrogen peroxide on the rate of myoblast proliferation was studied by measuring the reduction level of (3-(4,5- dimethylthiazole-2-yl))-2,5-diphenyltetrazolium bromide. To measure the expression of myostatin, a real-time polymerase chain reaction (PCR-RV) method was used. Results: During the work, it was clearly demonstrated that hydrogen peroxide has a significant cytostatic effect on myoblasts in vitro, inhibiting their proliferation. Ethoxidol in physiological concentration did not show toxic effects and did not inhibit cell proliferation. This antioxidant revealed a statistically significant protective effect on the cytostatic effect of hydrogen peroxide on myoblasts. In addition, this compound inhibited the expression of myostatin mRNA caused by exposure to hydrogen peroxide as a negative regulator of growth and differentiation of muscle tissue that occurs in response to exposure to reactive oxygen species. Conclusion: Hydrogen peroxide is one of the highly active forms of oxygen and has a significant cytostatic effect on myoblasts in vitro, suppressing their proliferation. 2-ethyl-6-methyl-3- hydroxypyridine malate neutralizes the toxic effect of peroxide, thereby indirectly having a positive effect on the rate of myoblast proliferation in vitro.


  • Open Access

    Study of the effect of the "Antiseptic Dorogov's stimulator" (ASD 2B-drops) on the growth of Mycobacterium tuberculosis strain

    by Сергей Владимирович Енгашев, Владимир Григорьевич Кукес, Александр Владимирович Поддубиков, Никита Геннадьевич Сидоров, Анна Юрьевна Леонова, Ольга Константиновна Парфенова, Альбина Амырхановна Газданова, Ольга Алексеевна Дорогова

    Objective - to study the effect of three different concentrations of the drug "ASD-2B drops" on the growth of M. tuberculosis strain № 22063. Materials and methods. The effect of three different concentrations of "ASD-2B drops" on the growth of M. tuberculosis strain № 22063 with a single addition of the drug into the reaction mixture was evaluated. Cultivation was carried out in Dubos broth for growing mycobacteria at 37°C for 20 days with periodic assessment of the turbidity index using a densitometer. Results. "ASD-2B drops" at a concentration of 750 µl in 10 ml of the reaction mixture after a single addition at the zero point inhibited the growth and accumulation of biomass of M.tuberculosis strain № 22063 for 10 days compared with the control. "ASD-2B drops" in lower concentrations (37.5 µl and 75 µl) contributed to an increase in the growth and accumulation of biomass of M.tuberculosis strain № 22063 compared with the control. Conclusion. The experiment demonstrated the ability of "ASD-2B drops" with a single addition to influence the growth and accumulation of biomass of M. tuberculosis strain № 22063, depending on the concentration of the drug. The presence of an inducing effect on the M. tuberculosis strain № 22063 provides a basis for further studies of the drug "ASD-2B drops".


  • Open Access

    Studying effects of lecithin and glucose on the growth properties of Streptococcus pneumoniae strains

    by Никита Геннадьевич Сидоров, Mechnikov Research Institute for Vaccines and Sera, Alexander V. Poddubikov

    The article presents the results of evaluating the effect of the addition of glucose and lecithin to the culture medium (Brain Heart Infusion Broth) on the rate and accumulation of biomass of various Streptococcus pneumoniae strains: No. 3405, serotype 4 (K-4); No.16082, serotype 14 (K-14); No. 3391, unstable in capsule formation (R-form). There was an increase in the biomass accumulation of strain No. 3405 (K-4) by 10% in the variant with the addition of lecithin; an increase in biomass by 64% and an elongation of the stationary phase in strain No. 16082 (K-14) when grown with the addition of glucose. There was an increase in the biomass growth of strain No. 3391 (R-form) by 37.5% and an extended duration of the stationary phase occurred when grown with lecithin. Based on the results obtained, it can be noted that lecithin and glucose had different effects on the growth of the studied strains of pneumococcus. The obtained data showed that strain No. 16082 (K-14) was the most promising and technologically advanced. Strain No. 16082 (K-14) had a more stable growth during three passages and in all three cases was identified with a high score value (2>) by MALDI-TOF mass spectrometry, had a higher level of biomass accumulation, and possessed a denser sediment of biomass. The study resulted in the selection of strain, optimal composition of the growth medium and suitable cultivation conditions to obtain a higher yield of S. pneumoniae biomass. Представлены результаты оценки влияния добавления в среду культивирования (сердечно-мозговой бульон) глюкозы и лецитина на скорость и накопление биомассы различных штаммов Streptococcus pneumoniae: № 3405, серотип 4 (К-4); № 16082, серотип 14 (К-14); № 3391, нестабильный в образовании капсулы (R-форма). Наблюдалось увеличение накопления биомассы штамма № 3405 (К-4) на 10% в варианте с добавлением лецитина; увеличение биомассы на 64% и удлинение стационарной фазы у штамма № 16082 (К-14) при выращивании с добавлением глюкозы; увеличение прироста биомассы штамма № 3391 (R-форма) на 37.5% и продление длительности стационарной фазы происходили при выращивании с лецитином. Показано, что лецитин и глюкоза по-разному влияли на рост исследованных штаммов пневмококка. Наиболее перспективным и технологичным оказался штамм № 16082 (К-14), который имел более стабильный рост в течение трех пассажей и во всех трех случаях идентифицировался с высоким коэффициентом достоверности («score value» 2>) при проведении MALDI-TOF масс-спектрометрии, обладал более высоким уровень накопления биомассы, отличался наиболее плотным осадком биомассы. В результате проведенных исследований отобран штамм, определены оптимальный состав питательной среды и соответствующие условия культивирования с целью получения наиболее высокого выхода биомассы S. pneumoniae.

  • Open Access

    Oxidative stress and inflammation in COVID-19 pathogenesis

    by Vladimir G. Kukes, Olga K. Parfenova, Nikita G. Sidorov, Yuri V. Olefir, Albina А. Gazdanova

    This study discusses the role of oxidative stress and inflammation in the development of severe acute respiratory syndrome (SARS) associated with COVID-19 caused by the novel SARS-CoV-2 coronavirus. An analysis of the literature revealed that the development of respiratory viral infections, including COVID-19, is usually accompanied by the accumulation of acidic metabolic products in the blood and tissues and, accordingly, oxidative stress and increased levels of cytokines. In this regard, it seems appropriate to use the second-generation low-toxic antioxidant Ethoxidol, manufactured in Russia, which reduces the intensity of inflammation, and also improves blood oxygen saturation.